-
September 28, 2012
The HealthCare unit of Bayer (BAYRY) recently announced that the US Food and Drug Administration (FDA) has cleared ...
-
September 27, 2012
Biogen Idec (BIIB) and partner, Swedish Orphan Biovitrum, recently presented positive phase III top-line results on ...
-
September 27, 2012
The US approval process of Bristol-Myers Squibb Company/Pfizer Inc.'s (BMY/PFE) anti-clotting drug Eliquis ...
-
September 27, 2012
New York, September 27th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) are trading
very close to ...
-
September 27, 2012
ETFs have earned the respect of countless investors as viable financial instruments well suited as core building ...
-
September 25, 2012
GlaxoSmithKline plc (GSK) performed disappointingly in the second quarter of 2012, missing the Zacks Consensus ...
-
September 25, 2012
Eli Lilly and Company's (LLY) Cialis (tadalafil) recently received a positive opinion from the Committee for ...
-
September 24, 2012
Recently, Bristol-Myers Squibb Company (BMY) and partner, Pfizer Inc. (PFE) received some encouraging news with the ...
-
September 24, 2012
Switzerland-based pharmaceutical company, Novartis AG (NVS) recently announced that the Committee for Medicinal ...
-
September 21, 2012
Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of GlaxoSmithKline's (GSK) ...
-
September 20, 2012
Cumberland Pharmaceuticals Inc. (CPIX) recently announced encouraging top-line results from a phase IV study on ...
-
September 18, 2012
Pfizer (PFE) and Chinese pharmaceutical company, Zhejiang Hisun Pharmaceuticals, recently announced the launch of ...
-
September 17, 2012
Merck & Co. (MRK) recently presented new data on its insomnia candidate, suvorexant, at the 21st Congress of the ...
-
September 17, 2012
In a bid to diversify its business into the pet care space, Perrigo Company (PRGO) inked a deal to buy substantially ...
-
September 14, 2012
We are maintaining our Neutral recommendation on AstraZeneca (AZN) with a target price of $49.00. The stock carries ...
-
September 13, 2012
Abbott Laboratories (ABT) recently announced that it is collaborating with Astellas Pharma Global Development for a ...
-
September 13, 2012
Sanofi (SNY) and its subsidiary Genzyme recently announced that their oral candidate for relapsing forms of multiple ...
-
September 12, 2012
Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of AstraZeneca's (AZN) ...
-
September 11, 2012
DRRX - Initiating Coverage of DURECT Corp. By Jason Napodano, CFA We are initiating coverage of DURECT ...
-
September 11, 2012
Mylan Inc. (MYL) recently announced that it has entered into a settlement agreement with Pfizer Inc. (PFE), ...
